Tracheal cellular immune response in chickens inoculated with Mycoplasma synoviae vaccine, MS-H or its parent strain 86079/7NS.
Cellular-response
Chickens
Cytokines
Mycoplasma synoviae
Vaccine
Journal
Veterinary immunology and immunopathology
ISSN: 1873-2534
Titre abrégé: Vet Immunol Immunopathol
Pays: Netherlands
ID NLM: 8002006
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
31
03
2022
revised:
25
07
2022
accepted:
01
08
2022
pubmed:
9
8
2022
medline:
27
8
2022
entrez:
8
8
2022
Statut:
ppublish
Résumé
Mycoplasma synoviae causes respiratory tract disease in chickens characterised by mild to moderate lymphoplasmacytic infiltration of the tracheal mucosa. MS-H (Vaxsafe1 MS, Bioproperties Pty Ltd.) is an effective live attenuated vaccine for M. synoviae, but the immunological basis for its mechanism of protection has not been investigated, and the phenotypes of lymphocytes and associated cytokines involved in the local adaptive immune response have not been described previously. In this study, specific-pathogen-free chickens were inoculated intra-ocularly at 3 weeks of age with either M. synoviae vaccine strain MS-H or vaccine parent strain 86079/7NS (7NS), or remained uninoculated. At 2-, 7- and 21 days post-inoculation (dpi), tracheal mucosal pathology, infiltrating lymphocytes subsets and transcription levels of mRNA encoding 8 cytokines were assessed using light microscopy, indirect immunofluorescent staining and RT-qPCR, respectively. After inoculation, tracheal mucosal thickness, tracheal mucosal lesions, and numbers of infiltrating CD4
Identifiants
pubmed: 35940079
pii: S0165-2427(22)00092-7
doi: 10.1016/j.vetimm.2022.110472
pii:
doi:
Substances chimiques
Bacterial Vaccines
0
Cytokines
0
Vaccines, Attenuated
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
110472Informations de copyright
Crown Copyright © 2022. Published by Elsevier B.V. All rights reserved.